Widespread antimicrobial use disrupts vital microbial communities that regulate Earth’s biogeochemical cycles, driving antimicrobial resistance, worsening human and environmental health, and significantly contributing to climate change.
|Articles|January 10, 2023
HIVMA Creates Paxlovid Clinical Resources for Treating People With HIV and Hepatitis C
Author(s)Contagion Editorial Team
They developed clinical guidance and other resources looking to address potential drug interactions with these patient populations who have COVID-19 and may be treated with Paxlovid.
Advertisement
HIVMA recently created guidance for treating patients with COVID-19 with nirmatrelvir-ritonavir (Paxlovid) who have HIV or hepatitis C.
“This brief was developed to respond to provider questions about treating patients with HIV and HCV with Paxlovid since one of the components of Paxlovid—ritonavir—is also part of many HIV and HCV treatment regimens,” HIVMA wrote in their guidance. “In addition, Paxlovid may result in significant drug interactions with other commonly used comedications in people with HIV or hepatitis C.”
The guidance includes a link to IDSA’s clinical guidance for using nirmatrelvir- ritonavir and potential drug interactions, answers to frequently asked questions about treating people with Paxlovid who have HIV or HCV, and links to other treatment resources.
"#Paxlovid is being underutilized to treat COVID-19 in people at risk for progressing to serious illness,” IDSA tweeted back on January 8.
To access the information, go
Advertisement
Related to this article
The latest CDC numbers show a 5.4% increase of measles cases from week-to-week. This year has already become the worst for the number of measles cases in the US since the disease was declared eliminated in 2000. With the start of respiratory virus season, case numbers are expected to continue to increase significantly.
New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available and fully analyzed.
Star Meat Delivery is recalling approximately 167,639 pounds of raw pork, beef, and goat products produced without federal inspection.
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: September 25, 2026
2
US Company Recalls Thousands of Pounds of Uninspected Meat
3
Carbapenem-Sparing Therapy for ESBL Bacteremia: New Trials, Old Questions
4
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
5